Stock Movers

iHeartPodcasts
undefined
Feb 24, 2026 • 5min

Home Depot Sales Top Estimates; Paramount to Submit Higher Offer for Warner Bros.; Hims’ Falls

A roundup of market movers and corporate developments in tech and retail. Coverage includes Home Depot’s better-than-expected same-store sales and caution on macro risks. Discussion of Paramount Skydance sweetening a bid for Warner Bros. Discovery. Reports on AI-driven strength lifting SanDisk, Corning and Keysight, plus worries around private credit affecting Blue Owl.
undefined
Feb 24, 2026 • 5min

StanChart's Swing, Telefonica & Unite Earnings

Louise Moon, Bloomberg breaking news editor who analyzes corporate earnings on air. She unpacks Standard Chartered’s weaker Q4 and $1.5bn buyback after a CFO shake-up. She reviews Telefónica’s in-line Q4 with strength in Spain and Brazil. She covers Unite’s slump in international student demand and its near-term headwinds.
undefined
Feb 24, 2026 • 5min

Novo Nordisk Slips, Fresenius & Telefónica Earnings

Chloe Malay, a Bloomberg reporter who analyzes company results, breaks down reactions to Novo Nordisk’s CagriSema trial miss. She covers Fresenius Medical Care’s muted outlook and why markets pulled back. She also explains Telefónica’s Q4 resilience, with Spain and Brazil offsetting weakness elsewhere.
undefined
6 snips
Feb 23, 2026 • 5min

PayPal Soars, American Express Sinks, Domino's Climbs

PayPal draws takeover chatter after banks and suitors circle its assets. American Express tumbles amid a stark AI-driven recession scenario that rattles credit-card outlooks. Domino’s stock climbs as same-store sales beat forecasts, helped by value promotions and stuffed-crust demand.
undefined
Feb 23, 2026 • 5min

Closing Bell: IBM Plunges, Door Dash Sinks Arcellx Soars

Big swing trades and takeover drama dominate the conversation. A biotech stock rockets after a major acquisition agreement. A legacy tech name tumbles amid claims about AI modernizing old code. A food-delivery company slides after a viral report questioning AI risks. Retailers and bond yields also draw attention as market responses unfold.
undefined
Feb 23, 2026 • 3min

Deere Falls, Veris Residential Climbs, Vanda Pharmaceuticals Surges as FDA Approves Bipolar, Schizophrenia Drug

Markets react to a bleak outlook for the farm economy after a major downgrade hits an agricultural giant. A residential real estate firm agrees to an all-cash buyout at a set price, sparking a big pop. A pharma company sees shares surge after regulatory approval for an oral treatment for bipolar I and schizophrenia.
undefined
Feb 23, 2026 • 4min

Novo Nordisk Sinks, Domino's Pizza Rises, International Paper Falls on Surprise Price Drop

A biotech trial shakes up shares after a next-generation obesity drug trails a rival in head-to-head results. A pizza chain posts stronger-than-expected comparable sales as pricing and fees boost revenue. A packaging maker tumbles on a surprise containerboard price drop that analysts say could pressure sector earnings.
undefined
Feb 23, 2026 • 5min

Gilead Rises with Acquisition, Novo Nordisk GLP1 Drops, Domino's Cooks

A big biotech takeover shakes up cancer drug pipelines with a nearly $7.8B deal. Results from the GLP-1 trials spark sharp market moves after a head-to-head weight‑loss comparison. Pizza chain sales and earnings momentum drive talks of restaurant-sector resilience and expansion.
undefined
Feb 23, 2026 • 4min

Gilead Slips on Arcellx Acquisition; Merck Rallies; Domino's Rises

A market roundup zeroing in on major pharma moves and big premarket movers. Discussion of a large biotech acquisition and its price tag. Coverage of a major drugmaker planning to split its human-health business. Breakdown of a pizza chain’s stronger-than-expected sales and what drove its gains.
undefined
Feb 23, 2026 • 4min

Novo Nordisk Data Dump, Johnson Matthey Falls, Enel Up

A deep dive into a surprising trial result that rattled a major pharma stock. A sharp fall in a UK chemicals group's shares after a buyer cut its offer. A regional bank gets a bullish upgrade that lifts its share price. Quick rundowns on drug format trends and market reactions to corporate deals.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app